Tandem Diabetes Care

Tandem Diabetes Care

World Rank (Jan-05-2024)
6,060
Market Cap (Jan-05-2024)
1.804 Billion USD
World Rank (Jul-30-2023)
5,234
Market Cap (Jul-30-2023)
2.305 Billion USD
World Rank (Jan-07-2022)
2,164
Market Cap (Jan-07-2022)
8.341 Billion USD
World Rank (Jan-01-2021)
2,563
Market Cap (Jan-01-2021)
5.951 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
TNDM
Market Cap (Mar-08-2026)
1.44
Employee Count
1,500
Employee Count as of Date
As on 2020
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
801 Million USD
Annual Operating Income in USD
-62 Million USD
Annual Net Income in USD
-95 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
1,052 Million USD
Total Liabilities in USD
612 Million USD
Total Equity in USD
439 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Medical Equipment / Instruments
HealthCare Products
Company Website
TANDEM DIABETES CARE INC
Yahoo
Yahoo @ Nasdaq
Company Profile

Tandem Diabetes Care is a Medical Device company. The company takes an innovative, user centric approach to the design, development and commercialization of products for people with diabetes who use insulin and manufactures and sells the t:slim X2 insulin pump with Control IQ technology. The headquarters is in USA.

Annual Results Summary

TANDEM DIABETES CARE - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-2022801-61 (Loss)-94 (Loss)
Dec-20217022215
Dec-2020498-7 (Loss)-34 (Loss)
Dec-2019362-16 (Loss)-24 (Loss)
Dec-2018183-44 (Loss)-122 (Loss)
Balance Sheet Summary

Total Assets as on Dec-2022 was 1,052 Million USD.

Total Liabilities as on Dec-2022 was 612 Million USD.

Total Equity as on Dec-2022 was 439 Million USD.

Founded Year
2006
IPO Year
2013
Stock Exchange
Nasdaq
Company SubCategory
Top Healthcare Companies in USA
Nasdaq Sector
Health Care
Nasdaq Industry
Medical/Dental Instruments

Share